Accession | SAMC1558479 |
---|---|
Accession in Other Database | GSA-Human: HRS147634 |
Sample name | ZL-075-N-224-M094-3 |
Title | first sample |
Sample type | Human sample |
Organism | Homo sapiens |
Description | no |
Attributes | *This sample record contains additional controlled-access information that is avaiable from GSA-Human by requesting study HRA000708 in the GSA-Human system. |
Release date | 2021-07-30 |
BioProject Accession | PRJCA003955 |
Submitter | HUI ZHANG (zhanghuirjh@gwcmc.org) |
Organization | Guangzhou women and children‘s medical center |
Submission date | 2023-06-18 |
Resource name | Description |
---|---|
GSA-Human (1) | - |
HRA000708 (Controlled Access) | The outcome of patients with relapsed/refractory ALL remains unsatisfactory, despite these patients generally receive more intense therapy. Glucocorticoid (GC) resistance is a leading cause of treatment failure and relapse in ALL. Abnormal NR3C1 transcription and/or translation are strongly associated with GC resistance, but the underlying molecular mechanism and the clinical value of NR3C1 alterations with GC resistance in ALL treatment remain unclear. |